New certificate series aims to empower students to accelerate the translation of aging science through the power of AI. Next month, Stanford University will launch a new program at the intersection of artificial intelligence and human longevity. The AI & Longevity Lab Certificate Series will exp…
Epirium Bio, a clinical-stage biopharmaceutical company, announced positive Phase 1 clinical trial results for MF-300, a first-in-class oral 15-PGDH enzyme inhibitor in development for sarcopenia. According to the company, the trial met its primary safety endpoint, with MF-300 generally well tolerat…
New peer-reviewed data reinforce that C2N’s PrecivityAD2™ blood test offers high accuracy in detecting brain amyloid pathology in patients with cognitive symptoms. According to the company, the test achieved 91 % accuracy, 90 % sensitivity, and 92 % specificity when compared against amyloid PET imag…
Experimental therapy cut precancerous skin lesions by 46%, offering a glimpse of how longevity science could reshape disease treatment. A longevity biotech may have found an easier way to tackle a common precancerous skin condition. Actinic keratosis (AK) is hardly a household term. Yet millions of …
GlycanAge’s Gordan Lauc on individuality, biology’s hidden signatures, and why epigenetic clocks may redefine how we measure aging. The Global Longevity Summit 2025, hosted by A4M, will bring together researchers, clinicians and entrepreneurs in Geneva next month to debate how emerging science can b…
AdVantage Therapeutics said it has been awarded a Phase II Small Business Innovation Research (SBIR) grant of $2.5 million from the National Institute on Aging (NIA) to support its Alzheimer’s drug candidate, AD04, according to the company. The company claims this non-dilutive funding will help adva…
GenSight Biologics has completed a fundraising round totalling €3,694,665.92, through subscriptions by its three existing shareholders — Heights Capital, Invus and Alumni Capital — using the same share-plus-warrant structure as its July private placement. The company said it will use up to 75 % of t…
Fractyl Health has released data from its REMAIN-1 Midpoint Cohort showing that patients treated with its investigational procedure, Revita®, continued to lose weight three months after stopping GLP-1 therapy, according to the company. In the randomized, double-blind, sham-controlled study (N = 45),…
L-Nutra and Parsley Health announced a strategic partnership to broaden access to nutrition-based interventions for metabolic conditions, according to the company. Under the alliance, patients of Parsley Health will gain access to L-Nutra’s Prolon® product suite, including the Prolon 5-Day Program, …
Grand Palais will host Europe’s longevity summit as AI and aging science converge on an international stage. Tech for Longevity will return to Paris this year, making the short journey from Station F to the newly reopened Grand Palais – but the leap in ambition could scarcely be greater. After drawi…
Alnylam Pharmaceuticals has released new post hoc results from its HELIOS-B Phase 3 study, reporting lower rates of gastrointestinal (GI) adverse events in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) treated with vutrisiran, compared to placebo. According to the company, in the over…
Biograph partners with Caristo Diagnostics to bring CaRi-Heart to the US and open preventive pathways in cardiology. Cardiovascular disease remains the leading global cause of death, and much of today’s prevention still waits for plaque to appear before action is taken. Caristo Diagnostics’ CaRi-Hea…
Anavex Life Sciences has published a preprint of its Phase IIb/III trial of oral blarcamesine, presenting a precision-medicine approach in Alzheimer’s disease, according to the company. The publication is hosted on medRxiv and is under submission to a peer-reviewed journal. The company claims that u…
Cognision has entered a strategic partnership with SOMNOmedics AG to advance the use of sleep biomarkers in pharmaceutical clinical trials. According to the company, Cognision will supply SOMNOmedics’ next-generation polysomnography (PSG) systems, tailored for use in regulated research environments.…
BIOARMOR reaches XPRIZE Healthspan semifinals with an intervention rooted in Malaysian heritage and clinical ambition. In partnership with our friends at TimePie, we continue our journey through the XPRIZE Healthspan Top 40, this heading to Malaysia and back to school to discover how a group of teen…
Rokit America, the U.S. subsidiary of biotechnology firm Rokit Healthcare, announced plans to accelerate its expansion across the Americas, positioning itself as a strategic hub for reverse-aging and regenerative medicine platforms, according to the company. Rokit America reported that since its fou…
C2N Diagnostics has submitted a regulatory filing to the U.S. Food and Drug Administration for its Alzheimer’s disease blood test, a milestone the firm calls a first in the field of medicine. The test combines high-resolution mass spectrometry to measure multiple plasma β-amyloid and tau peptide iso…
Emagene Life announced a global partnership with the Institute for Functional Medicine (IFM) to advance functional medicine, longevity and artificial intelligence–based health care, according to the company. Under the collaboration, Emagene Life will integrate IFM-trained practitioners into its netw…
Derm-Biome’s compound prevented epidermal thickening, reduced cellular senescence and preserved collagen levels under UV stress. Skin-focused biopharma Derm-Biome Pharmaceuticals is advancing an experimental topical compound that may offer a new approach to slowing or preventing skin aging caused by…
LifeVantage Corporation said it has closed its previously announced acquisition of LoveBiome, a direct sales firm focused on microbiome and gut-health solutions. According to the company, the transaction includes the transfer of key operating assets and retention of critical LoveBiome personnel. Lif…
